Charles and Lynn Schusterman Family Philanthropies

Charles and Lynn Schusterman Family Philanthropies is an independent non-profit private foundation based in Tulsa, Oklahoma, established in 1987. The foundation is committed to advancing a more just and inclusive society through targeted philanthropic efforts. In the United States, it focuses on key areas such as criminal justice reform, democracy and voting rights, public education, and gender and reproductive equity, while also supporting initiatives that benefit the community in Tulsa. Additionally, the foundation invests in strengthening the Jewish community, emphasizing engagement among young people and fostering connections with Israel. Through its initiatives, Charles and Lynn Schusterman Family Philanthropies aims to drive systemic change by supporting leaders, organizations, and public policy efforts.

Lisa Eisen

Co-President

Julie Mikuta Ph.D

Co-President

20 past transactions

Retrain.ai

Venture Round in 2022
Retrain AI is a talent intelligence platform that leverages artificial intelligence and machine learning to enhance workforce development. The platform assists organizations in hiring, retaining, and upskilling employees by analyzing skills and identifying talent gaps. By mapping an organization's skills inventory, Retrain AI can recommend personalized training pathways tailored to individual needs. Its proprietary models also forecast emerging job trends and skill shifts, enabling businesses to adapt to future demands effectively. Through these insights, organizations can optimize their workforce strategies and better equip their employees for evolving roles.

Pickle Robot

Series A in 2022
Pickle Robot Company, founded in 2018 and based in Cambridge, Massachusetts, develops an innovative package handling robot designed to automate critical tasks in the e-commerce supply chain. The company's first robot, named Dill, addresses the physically demanding nature of package handling, which often results in high employee turnover. Dill is capable of performing multiple shifts and effectively communicates with human workers, continuously developing new skills to enhance operations. The robot's capabilities include loading and unloading feeder trucks, palletizing and depalletizing mixed parcels, preloading last-mile delivery vehicles, and sorting packages. By automating these processes, Pickle Robot aims to help logistics companies reduce labor costs and increase efficiency, addressing a significant bottleneck in the rapidly growing e-commerce sector.

Navina

Series B in 2022
Navina is a technology company that has developed an AI-driven platform aimed at transforming disorganized patient data into clear and actionable patient portraits. This innovative approach allows physicians to quickly assess complex cases, significantly enhancing the diagnostic process and patient care. By utilizing artificial intelligence and machine learning, Navina's platform organizes essential patient information in a way that is intuitively accessible, ensuring that critical data is easily understood and contextually relevant. This capability not only improves patient wellness but also supports better financial outcomes for healthcare providers and payers. Additionally, Navina collaborates with the American Academy of Family Physicians Innovation Lab, further solidifying its commitment to advancing healthcare through technology.

Athletes Unlimited

Venture Round in 2022
Athletes Unlimited (AU) operates a series of professional sports leagues, including basketball, softball, volleyball, and lacrosse. The organization is dedicated to empowering athletes by promoting them as leaders and fostering a sense of inclusive ownership. AU's innovative player-centric model aims to enhance the long-term financial and personal well-being of athletes, allowing them to continue earning revenue throughout their careers. Additionally, the platform seeks to strengthen the connection between fans and the games by introducing novel approaches both on and off the field.

Invisible Universe

Series A in 2022
Invisible Universe is an innovative animation studio focused on developing original character intellectual property for social media and web3 platforms. The company aims to create popular animated franchises more efficiently than traditional animation models. By collaborating with celebrities and utilizing advanced animation technology and software, Invisible Universe combines creative talent with the extensive reach of social media to engage entertainment users. Its mission is to redefine how animated characters are conceived and brought to audiences, positioning itself at the forefront of the next generation of animated franchises.

Voyantis

Seed Round in 2022
Voyantis provides an AI-driven growth platform focused on customer acquisition and lifecycle optimization. The company enables businesses to efficiently acquire, retain, and nurture high-value customers through its predictive and prescriptive AI capabilities. By eliminating the uncertainties associated with assessing customer potential, Voyantis offers automated actions to guide businesses on the next steps and the timing of their engagements. Its no-code platform simplifies the integration of optimization strategies based on predictive lifetime value modeling, allowing organizations to enhance their user interactions through artificial intelligence-driven orchestration and automation.

Massive Bio

Series A in 2022
Massive Bio, Inc. is a New York-based company that offers testing and treatment advisory services tailored to cancer patients and oncologists. Founded in 2014, the company employs an artificial intelligence-powered platform to connect patients with clinical trials and optimize cancer care. Through its Personalized Oncology Advisor, Massive Bio integrates cancer genomics and targeted therapies into clinical decision-making, providing both diagnostic and treatment options, including access to clinical trials. The company operates two main platforms: a business-to-consumer (B2C) platform that delivers on-demand products and services for patients and their oncologists, and a business-to-business (B2B) platform designed for hospitals and insurance companies. Additionally, Massive Bio addresses patient enrollment challenges in clinical trials by utilizing advanced technology and real-world data to streamline processes, ensuring patients receive effective treatment while minimizing financial burdens. The company serves a diverse clientele that includes patients, oncologists, hospitals, and payers.

ConcertoCare

Series B in 2022
ConcertoCare is dedicated to delivering primary and complex care to seniors and other adult patients with unmet health and social needs. The company employs a tech-enabled, value-based care model that features three distinct in-home care approaches, all supported by its proprietary population health and analytics platform. ConcertoCare's interdisciplinary teams, led by experienced professionals in home-based geriatric medicine, digital health, palliative care, and healthcare analytics, utilize clinical decision support tools to enhance patient care. This innovative model aims to lower overall healthcare costs while improving health outcomes for its patients.

Esusu

Series B in 2022
Esusu is a financial technology platform that leverages data solutions to help residents and improve property performance. Esusu was created on the premise that no matter where you come from, the color of your skin, and your financial identity should never determine where you end up in life. This allows renters to build and establish their credit scores while helping property owners mitigate against initiating evictions, powered by differentiated data and insights. It was founded in 2016 and headquartered in New York, United States.

Navina

Series A in 2021
Navina is a technology company that has developed an AI-driven platform aimed at transforming disorganized patient data into clear and actionable patient portraits. This innovative approach allows physicians to quickly assess complex cases, significantly enhancing the diagnostic process and patient care. By utilizing artificial intelligence and machine learning, Navina's platform organizes essential patient information in a way that is intuitively accessible, ensuring that critical data is easily understood and contextually relevant. This capability not only improves patient wellness but also supports better financial outcomes for healthcare providers and payers. Additionally, Navina collaborates with the American Academy of Family Physicians Innovation Lab, further solidifying its commitment to advancing healthcare through technology.

Creapaper

Series B in 2021
Creapaper GmbH, founded in 2012 and based in Hennef, Germany, specializes in producing an innovative raw material for the paper industry, primarily using grass fibers. The company offers processed paper products that integrate germinable seeds, including flower and herb boxes. By utilizing dried hay through a patented process tailored to specific paper mill requirements, Creapaper provides an alternative to traditional raw materials like wood and recycled paper. This substitution not only reduces the reliance on virgin fibers but also significantly lowers CO2 emissions during production by up to 75%. Creapaper's approach emphasizes sustainability and aims to mitigate plastic pollution while promoting eco-friendly practices within the paper and packaging sectors.

Syng

Series A in 2021
Syng is an audio company dedicated to changing how people interact with sound. It develops a smart audio system that emphasizes high sound quality and innovative design. By offering a range of hardware and software products, Syng empowers both creators and listeners to engage with, explore, and share sound in transformative ways. The company's focus on the intersection of design and technology allows it to deliver a unique audio experience that enhances the overall relationship individuals have with sound.

Retrain.ai

Venture Round in 2021
Retrain AI is a talent intelligence platform that leverages artificial intelligence and machine learning to enhance workforce development. The platform assists organizations in hiring, retaining, and upskilling employees by analyzing skills and identifying talent gaps. By mapping an organization's skills inventory, Retrain AI can recommend personalized training pathways tailored to individual needs. Its proprietary models also forecast emerging job trends and skill shifts, enabling businesses to adapt to future demands effectively. Through these insights, organizations can optimize their workforce strategies and better equip their employees for evolving roles.

NextSilicon

Series C in 2021
NextSilicon Ltd. is a technology company based in Tel Aviv-Yafo, Israel, founded in 2018. It specializes in designing and developing advanced computer processing technology that integrates software-defined hardware. The company offers innovative solutions aimed at enhancing high-performance computing (HPC) architectures, addressing fundamental challenges within the industry. By leveraging novel chip designs and software algorithms, NextSilicon enables businesses to accelerate compute-intensive applications, thereby creating opportunities for innovation in supercomputing. Through its unique approach, NextSilicon seeks to advance the future of computing technology.

Immunai

Series A in 2021
Immunai Inc. is a biotechnology company that specializes in developing an artificial intelligence-based immune profiling platform aimed at enhancing drug development and improving disease detection, diagnosis, and treatment. The company utilizes single-cell genomics and machine learning algorithms to conduct high-resolution profiling of the immune system, generating valuable biological insights that facilitate research and development. Immunai's platform focuses on biomarker discovery, enabling the identification of how immune cells respond to various conditions, and supports the development of therapies for oncology and autoimmune disorders. Established in 2018 and headquartered in New York City, Immunai also maintains offices in San Francisco and Tel Aviv, collaborating with academic institutions, biopharmaceutical firms, and biotechnology companies to advance its mission of mapping the immune system and its functions.

Gro Intelligence

Series B in 2021
Gro Intelligence, Inc. is an agricultural data analytics company that provides insights to enhance productivity and access to capital in the farming sector. Founded in 2014 and headquartered in New York, with an additional office in Nairobi, the company employs proprietary algorithms and artificial intelligence to aggregate, process, and analyze data related to weather patterns, trade flows, pricing dynamics, and production. Its platform offers computational and visualization tools that enable financial institutions, corporations, and government entities to make informed decisions regarding supply chains, climate change, and food security. By bridging data gaps across global agriculture, Gro Intelligence synthesizes diverse farming data points from various sources, delivering a comprehensive view of factors influencing commodity markets. The company emphasizes the importance of combining artificial intelligence with human insight to transform raw agricultural and climate data into actionable knowledge.

NextSilicon

Series B in 2020
NextSilicon Ltd. is a technology company based in Tel Aviv-Yafo, Israel, founded in 2018. It specializes in designing and developing advanced computer processing technology that integrates software-defined hardware. The company offers innovative solutions aimed at enhancing high-performance computing (HPC) architectures, addressing fundamental challenges within the industry. By leveraging novel chip designs and software algorithms, NextSilicon enables businesses to accelerate compute-intensive applications, thereby creating opportunities for innovation in supercomputing. Through its unique approach, NextSilicon seeks to advance the future of computing technology.

SQream

Series B in 2020
SQream Technologies USA, Inc., established in 2010, specializes in big data analytics, offering a GPU-accelerated SQL database named SQream DB. This columnar database employs aggressive compression techniques to optimize storage and query speed. Additionally, SQream provides xDR Repository for telecoms, enabling multi-source data storage, analysis, and rapid value extraction. For bioinformatics, SQream offers GenomeStack, a platform for data storage and real-time correlated analytics. The company serves diverse sectors, including genome research, finance, cybersecurity, telecom, and IoT, and has strategic partnerships with DataDirect Networks, Telogic, and Moyo Business Advisory. With offices in New York, London, and a R&D center in Tel Aviv, SQream empowers businesses to analyze larger datasets faster and at lower costs.

Mursion

Series A in 2019
Mursion, Inc. is a company that specializes in a virtual reality platform designed to enhance the interpersonal skills of professionals across various sectors, including healthcare, education, hospitality, and finance. By combining artificial intelligence with live actors, Mursion creates personalized simulations that replicate challenging workplace scenarios, allowing users to engage in immersive practice and take risks to improve their performance. The platform aims to provide authentic environments where individuals can develop essential skills necessary for navigating complex interpersonal exchanges in their careers. Founded in 2014 and headquartered in San Francisco, California, Mursion was previously known as AMITIES, INC. and rebranded in May 2015.

SpaceIL

Grant in 2014
SpaceIL is an Israeli nonprofit founded at the end of 2010, when three young engineers with the dream of landing the first Israeli spacecraft on the Moon entered the Google Lunar X Prize (GLPX) competition.In just three years, the organization has scaled into a national movement comprised of nearly twenty full-time staff, over 250 volunteers, and a network of hundreds of renowned academics, business leaders, and industry experts. President Shimon Peres is among the project’s many enthusiastic supporters.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.